We are international
• health professionals TEXT SIZE   

Conversations at EHA 2008
Roman Hájek, MD
Masaryk University, Brno, Czech Republic
We spoke to Dr. Hájek, chairman of the Czech Myeloma Group, about what he sees as the major advances in myeloma treatment based on this conference (EHA) and ASCO, which just concluded. The first of his two key points is his concern that studies of new drug combinations may not be cost effective for myeloma patients in his country.

Be the first to comment

 related articles